Hereditary Amyloidosis Canada invites you to a join us on May 13, May 20 and May 27, 2020 at 8:00 p.m. EDT for our first-ever interactive webinar series for Canadian hATTR patients, families and caregivers to learn about the fundamentals of advocacy and HAC’s recently launched advocacy campaign to support publicly funded access to new treatments.
- Webinar #1: This presentation will help educate the hATTR amyloidosis community on the fundamentals of advocacy
- Webinar #2: This presentation will take a deeper look at telling your personal story as a core component of advocacy and explore the drug approval and reimbursement processes in Canada
- Webinar #3: This presentation will delve deeper into how and when to use advocacy tools, and take a closer look at the specific tools that are available to the hATTR amyloidosis community
HAC is dedicated to connecting all patients and families affected by hATTR amyloidosis to the community and the resources they need. One of the ways we do this is through our advocacy efforts. We help empower the hATTR community to advocate to federal, provincial and territorial governments on issues that are important to you.
Don’t forget to mark your calendars for May 13, May 20 and May 27 and stay tuned for more details and a registration link for the webinars.
For more information, contact Anne Marie Carr, Founder & Executive Director, by email at: firstname.lastname@example.org or by phone at: 1-905-580-2802.